v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 36,277 $ 19,703
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 57,866 44,911
Reduction in the carrying amount of right-of-use assets 16,114 15,174
Amortization of deferred contract acquisition costs 73,957 63,568
Accretion of discount on marketable investments (3,271) (6,658)
Provision for credit losses 1,114 1,254
Stock-based compensation 100,571 114,443
Amortization of discount and issuance costs on convertible senior notes 2,740 3,614
Impairment charges of long-lived assets 8,518 835
Interest on finance lease obligations 510 743
Deferred taxes - excluding tax benefit from acquisition 175 23
Deferred taxes - tax adjustments from an acquisition 0 524
Other 1,249 159
Changes in operating assets and liabilities:    
Accounts receivable (28,587) (24,569)
Prepaid expenses and other current assets (13,466) 1,291
Deferred contract acquisition costs (100,591) (85,513)
Other assets 6,722 2,645
Accounts payable 13,296 523
Accrued and other current liabilities (19,871) (8,073)
Deferred revenue 7,702 (3,514)
Other liabilities (including non-current portions of operating and finance lease liabilities) 3,334 1,558
Net cash provided by operating activities 164,359 142,641
Cash flows from investing activities:    
Purchases of marketable investments (288,134) (569,150)
Proceeds from sales of marketable investments 62,806 114,406
Proceeds from maturities of marketable investments 256,766 622,026
Purchases of property and equipment (27,947) (18,722)
Capitalization of internal-use software development costs (28,472) (29,121)
Payments of initial direct lease costs 0 (286)
Net cash (used in) provided by investing activities (24,981) 119,153
Cash flows from financing activities:    
Repayment of outstanding 2025 convertible senior notes at maturity 0 (434,405)
Proceeds from exercise of common stock options 3,386 3,118
Proceeds from sale of common stock under ESPP 7,008 7,921
Cash paid for repurchase of the Company's common stock (100,011) 0
Principal repayment on financing liability (10,779) 0
Payment of finance lease liabilities (7,259) (7,183)
Net cash used in financing activities (107,655) (430,549)
Net increase (decrease) in cash, cash equivalents and restricted cash 31,723 (168,755)
Cash, cash equivalents and restricted cash:    
Total cash, cash equivalents and restricted cash 234,131 364,185
Total cash, cash equivalents and restricted cash 265,854 195,430
Supplemental disclosures of cash flow data:    
Cash paid for interest 9,311 9,450
Cash paid for income taxes 2,161 3,164
Non-cash investing and financing activities:    
Maintenance services purchased through financing 48,276 0
Equipment purchased and unpaid at period-end 13,877 11,414
Stock-based compensation included in capitalized software development costs 6,822 7,796
Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Condensed Consolidated Balance Sheets - Beginning of Period:    
Cash and cash equivalents 232,084 362,546
Restricted cash in other assets 2,047 1,639
Total cash, cash equivalents and restricted cash 234,131 364,185
Cash and cash equivalents 263,830 193,409
Restricted cash in other assets 2,024 2,021
Total cash, cash equivalents and restricted cash $ 265,854 $ 195,430